RhumbLine Advisers’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.16M Sell
183,239
-16,659
-8% -$381K ﹤0.01% 1560
2026
Q1
$4.66M Buy
199,898
+538
+0.3% +$11.6K ﹤0.01% 1429
2025
Q4
$3.99M Buy
199,360
+5,401
+3% +$105K ﹤0.01% 1521
2025
Q3
$3.54M Buy
193,959
+7,875
+4% +$154K ﹤0.01% 1599
2025
Q2
$3.74M Buy
186,084
+7,954
+4% +$153K ﹤0.01% 1564
2025
Q1
$3.23M Sell
178,130
-9,188
-5% -$165K ﹤0.01% 1576
2024
Q4
$3.25M Buy
187,318
+3,931
+2% +$75.5K ﹤0.01% 1633
2024
Q3
$3.54M Sell
183,387
-21,395
-10% -$394K ﹤0.01% 1604
2024
Q2
$3.36M Sell
204,782
-3,325
-2% -$51.6K ﹤0.01% 1613
2024
Q1
$3.17M Sell
208,107
-429
-0.2% -$6.74K ﹤0.01% 1666
2023
Q4
$3.34M Buy
208,536
+3,242
+2% +$45.3K ﹤0.01% 1639
2023
Q3
$2.67M Sell
205,294
-2,154
-1% -$28K ﹤0.01% 1716
2023
Q2
$2.64M Buy
207,448
+10,717
+5% +$134K ﹤0.01% 1755
2023
Q1
$2.21M Buy
196,731
+10,670
+6% +$129K ﹤0.01% 1754
2022
Q4
$2.46M Buy
186,061
+2,461
+1% +$32.4K ﹤0.01% 1675
2022
Q3
$2.13M Buy
183,600
+3,767
+2% +$51.7K ﹤0.01% 1725
2022
Q2
$2.65M Buy
179,833
+17,045
+10% +$279K ﹤0.01% 1616
2022
Q1
$3.15M Sell
162,788
-16,531
-9% -$295K ﹤0.01% 1578
2021
Q4
$3.09M Sell
179,319
-5,812
-3% -$99K ﹤0.01% 1636
2021
Q3
$3.09M Sell
185,131
-42,276
-19% -$632K ﹤0.01% 1645
2021
Q2
$3.05M Buy
227,407
+12,746
+6% +$159K ﹤0.01% 1714
2021
Q1
$2.56M Buy
214,661
+10,901
+5% +$132K ﹤0.01% 1791
2020
Q4
$2.52M Buy
203,760
+10,380
+5% +$112K ﹤0.01% 1736
2020
Q3
$2.02M Sell
193,380
-20,520
-10% -$261K ﹤0.01% 1674
2020
Q2
$2.99M Sell
213,900
-6,126
-3% -$83.3K 0.01% 1493
2020
Q1
$2.59M Buy
220,026
+4,624
+2% +$61.2K 0.01% 1402
2019
Q4
$3.05M Buy
215,402
+9,529
+5% +$117K 0.01% 1555
2019
Q3
$2.17M Buy
205,873
+3,547
+2% +$42.4K ﹤0.01% 1700
2019
Q2
$2.95M Buy
202,326
+3,453
+2% +$48.9K 0.01% 1492
2019
Q1
$2.79M Buy
198,873
+1,632
+0.8% +$26.4K 0.01% 1518
2018
Q4
$3.44M Buy
197,241
+31,815
+19% +$517K 0.01% 1325
2018
Q3
$2.52M Sell
165,426
-5,132
-3% -$73.9K ﹤0.01% 1531
2018
Q2
$2.35M Sell
170,558
-1,078
-0.6% -$16.2K ﹤0.01% 1590
2018
Q1
$2.86M Buy
171,636
+131
+0.1% +$2.02K 0.01% 1395
2017
Q4
$2.43M Buy
171,505
+19,735
+13% +$263K ﹤0.01% 1516
2017
Q3
$2.14M Buy
151,770
+1,019
+0.7% +$13.5K ﹤0.01% 1569
2017
Q2
$1.93M Sell
150,751
-6,037
-4% -$75.7K ﹤0.01% 1601
2017
Q1
$2.17M Buy
156,788
+44,662
+40% +$526K 0.01% 1500
2016
Q4
$1.2M Buy
112,126
+20,028
+22% +$210K ﹤0.01% 1761
2016
Q3
$1.01M Buy
92,098
+1,370
+2% +$16K ﹤0.01% 1792
2016
Q2
$955K Sell
90,728
-3,475
-4% -$41.1K ﹤0.01% 1809
2016
Q1
$1.19M Buy
94,203
+1,465
+2% +$16.1K ﹤0.01% 1685
2015
Q4
$977K Buy
92,738
+5,810
+7% +$53.4K ﹤0.01% 1816
2015
Q3
$624K Buy
86,928
+4,387
+5% +$59.6K ﹤0.01% 2078
2015
Q2
$1.49M Sell
82,541
-3,170
-4% -$54.4K ﹤0.01% 1612
2015
Q1
$1.35M Buy
85,711
+10,905
+15% +$165K ﹤0.01% 1673
2014
Q4
$1.06M Sell
74,806
-1,895
-2% -$28.5K ﹤0.01% 1769
2014
Q3
$1.31M Sell
76,701
-3,320
-4% -$76.3K ﹤0.01% 1583
2014
Q2
$2.38M Sell
80,021
-51
-0.1% -$1.22K 0.01% 1255
2014
Q1
$2M Sell
80,072
-3,785
-5% -$111K 0.01% 1348
2013
Q4
$2.41M Sell
83,857
-7,272
-8% -$213K 0.01% 1255
2013
Q3
$3M Sell
91,129
-11,512
-11% -$358K 0.01% 1095
2013
Q2
$3.19M Buy
+102,641
New +$2.75M 0.01% 1022

Other funds holding INVA

RhumbLine Advisers's INVA Position: Q2 2026 in Review

RhumbLine Advisers reduced its Innoviva (INVA) stake by 8.3% in Q2 2026, selling an estimated $381K and leaving 183,239 shares worth $4.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1560.

RhumbLine Advisers first reported a position in INVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.66M in Q1 2026. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • RhumbLine Advisers held 183,239 shares of Innoviva worth $4.16M as of Q2 2026.
  • RhumbLine Advisers sold 16,659 Innoviva shares in Q2 2026, an estimated $381K.
  • Innoviva made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1560 holding.
  • RhumbLine Advisers first reported a position in Innoviva in Q2 2013 and has held it in 53 quarters since.
  • RhumbLine Advisers's Innoviva position peaked at $4.66M in Q1 2026.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.